Tiny study checks if novel bacterium is safe for people
NCT ID NCT07660107
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed trial tested whether a heat-killed bacterium called KGA-10 (also known as NeuroAlly) is safe and tolerable for healthy adults. Eight participants took either KGA-10 or a placebo daily for one week. Researchers tracked side effects and satisfaction using surveys. The study only looked at safety, not any health benefits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Heat-killed Mycolicibacterium petrae KGA-10 (a type of bacterium, also called NeuroAlly)
- What this could lead to
- If safe, this could pave the way for future studies exploring whether KGA-10 has any health benefits.
- What could go wrong
- This was a very small, early safety study with only 8 people. It does not test whether KGA-10 helps any condition, and larger studies are needed to confirm safety.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Colorado, Boulder - WILD campus
Boulder, Colorado, 80301, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a two-drug combo better tame prostate trouble?
- New vaginal capsule aims to tackle stubborn bacterial vaginosis
- New painkiller oliceridine tested against morphine in back surgery patients
- New online guide aids dementia caregivers in tough gun safety choices
- New supplement shows promise for stress and sleep in healthy adults
- New wound dressing aims to speed healing in chronic wounds